Neoplasms, Malignant

Map of Tumor Genetic Actionability in Argentina

Existential Distress in Patients with Advanced Cancer and Their Caregivers

A Phase 1 Dose Escalation and Expansion Study of AK117

A Study of AK112, a PD-1/VEGF Bispecific Antibody, for Advanced Solid Tumors

Studying An Investigational Drug Crizotinib (PF-02341066) In Non Non-Small Cell Lung Cancer Tumors That Are Positive For Anaplastic Lymphoma Kinase (ALK)

A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK117 as Monotherapy or in Combination With AK104

Prophylactic Mesh Placement During Stoma Closure After Low Anterior Resection

Perceptions, Experiences, and Activity in CancEr Survivors During COVID-19

Oxygen Measurements in Subcutaneous Tumors by EPR Oximetry Using OxyChip

Clinical Application of Super-resolution Ultrasound(SR-US) Imaging in Solid Tumors

Oxygen Atomizing Inhalation of EGCG in the Treatment Interstitial Pneumonia in Cancer Patients

A Study of B1962, a PD-L1/VEGF Bispecific Antibody Fusion Protein, for Advanced Solid Tumors

Early Clinical Evaluation of 18F-LY3546117 in Tumor Imaging

Improved Adherence With Extended Venous Thromboembolism Prophylaxis After Major Cancer Surgery

Thromboembolic Risk Screening in Patients With Cancer and COVID-19

Clinical Outcomes of NOSES Versus Traditional Robotic-assisted Surgery for Patients With Colorectal Cancer

EPR Tumor Oximetry With CE India Ink

Cancer Survivors Acute Exercise Response 1

A Study of Dalotuzumab + MK-2206, Dalotuzumab + MK-0752, and Dalotuzumab + Ridaforolimus Combination Therapies in Participants With Advanced Cancer (MK-0646-027)

Dose-escalation, Safety, Pharmacokinetics Study of AVE8062 Combined With Bevacizumab in Patients With Advanced Solid Tumors